atropine: is administered preoperatively

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
is administered preoperatively 1.00
be administered with neostigmine 0.87
is administered 0.80
be given with neostigmine 0.78
be contraindicated in prostatic hypertrophy 0.78
be used for bradycardia 0.76
be given for bradycardia 0.75
be contraindicated in myasthenia gravis 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.42
¬ Salient(atropine, is administered preoperatively)

Similarity expansion

0.67
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.05
¬ Typical(atropine, is administered)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.20
¬ Plausible(atropine, is administered)
0.59
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.87
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.42
¬ Typical(atropine, be administered with neostigmine)
0.56
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.87
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.44
¬ Plausible(atropine, be administered with neostigmine)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.75
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.24
¬ Remarkable(atropine, be given for bradycardia)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.75
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.31
¬ Salient(atropine, be given for bradycardia)
0.52
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.80
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.41
¬ Salient(atropine, is administered)
0.52
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.87
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.51
¬ Salient(atropine, be administered with neostigmine)
0.51
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.76
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.38
¬ Remarkable(atropine, be used for bradycardia)
0.50
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.40
¬ Salient(atropine, be used for bradycardia)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.75
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.43
¬ Plausible(atropine, be given for bradycardia)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.58
¬ Typical(atropine, be given with neostigmine)
0.48
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.76
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.47
¬ Plausible(atropine, be used for bradycardia)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.78
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.59
¬ Typical(atropine, be contraindicated in prostatic hypertrophy)
0.47
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.75
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.49
¬ Remarkable(atropine, be contraindicated in myasthenia gravis)
0.47
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.87
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.67
¬ Remarkable(atropine, be administered with neostigmine)
0.46
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.59
¬ Typical(atropine, be used for bradycardia)
0.45
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.78
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.58
¬ Plausible(atropine, be given with neostigmine)
0.44
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.75
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.65
¬ Typical(atropine, be given for bradycardia)
0.43
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.78
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.63
¬ Plausible(atropine, be contraindicated in prostatic hypertrophy)
0.42
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.78
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.69
¬ Remarkable(atropine, be given with neostigmine)
0.40
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.78
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.68
¬ Salient(atropine, be given with neostigmine)
0.38
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.78
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.78
¬ Remarkable(atropine, be contraindicated in prostatic hypertrophy)
0.36
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.75
Evidence: 0.52
Typical(atropine, is administered preoperatively)
Evidence: 0.91
¬ Typical(atropine, be contraindicated in myasthenia gravis)
0.36
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.78
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.79
¬ Salient(atropine, be contraindicated in prostatic hypertrophy)
0.35
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.75
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.83
¬ Plausible(atropine, be contraindicated in myasthenia gravis)
0.34
Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.80
Evidence: 0.45
Remarkable(atropine, is administered preoperatively)
Evidence: 0.91
¬ Remarkable(atropine, is administered)
0.32
Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.75
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.85
¬ Salient(atropine, be contraindicated in myasthenia gravis)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.42
Salient(atropine, is administered preoperatively)
Evidence: 0.52
¬ Typical(atropine, is administered preoperatively)
Evidence: 0.45
¬ Remarkable(atropine, is administered preoperatively)

Typical implies Plausible

0.34
Rule weight: 0.48
Evidence weight: 0.71
Similarity weight: 1.00
Evidence: 0.45
Plausible(atropine, is administered preoperatively)
Evidence: 0.52
¬ Typical(atropine, is administered preoperatively)